Mohammadreza Alizadeh-Ghodsi
Overview
Explore the profile of Mohammadreza Alizadeh-Ghodsi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
93
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alizadeh-Ghodsi M, Pourhassan-Moghaddam M, Zavari-Nematabad A, Walker B, Annabi N, Akbarzadeh A
Part Part Syst Charact
. 2024 May;
36(2).
PMID: 38716148
Quantum dots (QDs) with a nanoscale size range have attracted significant attention in various areas of nanotechnology due to their unique properties. Different strategies for the synthesis of QD nanoparticles...
2.
Shrestha R, Nassar Z, Hanson A, Iggo R, Townley S, Dehairs J, et al.
Cancer Res
. 2024 Apr;
84(14):2313-2332.
PMID: 38657108
Solid tumors are highly reliant on lipids for energy, growth, and survival. In prostate cancer, the activity of the androgen receptor (AR) is associated with reprogramming of lipid metabolic processes....
3.
Alizadeh-Ghodsi M, Owen K, Townley S, Zanker D, Rollin S, Hanson A, et al.
Cancer Res Commun
. 2023 Mar;
2(7):706-724.
PMID: 36923279
Significance: Our study demonstrates that potent androgen stimulation of prostate cancer cells can elicit a viral mimicry response, resulting in enhanced IFN signaling. This finding may have implications for the...
4.
Khademi B, Khorrami M, Ayromlou H, Rikhtegar R, Moghadam E, Tahmasebivand M, et al.
J Neuroimmunol
. 2021 Feb;
353:577507.
PMID: 33548618
Interferon-β (IFN-β) is among the first drugs used for reducing the symptoms of multiple sclerosis (MS). Many studies show that the genetic predisposition of patients might modulate their response to...
5.
Del Bakhshayesh A, Annabi N, Khalilov R, Akbarzadeh A, Samiei M, Alizadeh E, et al.
Artif Cells Nanomed Biotechnol
. 2017 Jul;
46(4):691-705.
PMID: 28697631
The tissue engineering field has developed in response to the shortcomings related to the replacement of the tissues lost to disease or trauma: donor tissue rejection, chronic inflammation and donor...
6.
Zavari-Nematabad A, Alizadeh-Ghodsi M, Hamishehkar H, Alipour E, Pilehvar-Soltanahmadi Y, Zarghami N
Anal Bioanal Chem
. 2016 Nov;
409(5):1301-1310.
PMID: 27822647
Reactivation of telomerase, which is observed in more than 85% of all known human tumours, is considered a promising tumour marker for cancer diagnosis. With respect to the biomedical importance...
7.
Alizadeh-Ghodsi M, Zavvari A, Ebrahimi-Kalan A, Shiri-Shahsavar M, Yousefi B
Nutr Neurosci
. 2016 Oct;
21(2):92-96.
PMID: 27697018
Multiple sclerosis (MS) is a disease which manifests demyelination of neuronal cells in the brain. Despite extensive research on the mechanisms of disease development and progression, the exact mechanism is...
8.
Alizadeh-Ghodsi M, Zavari-Nematabad A, Hamishehkar H, Akbarzadeh A, Mahmoudi-Badiki T, Zarghami F, et al.
Biosens Bioelectron
. 2016 Feb;
80:426-432.
PMID: 26874110
Telomerase, which has been detected in almost all kinds of cancer tissues, is considered as an important tumor marker for early cancer diagnostics. In the present study, an electrochemical method...